iRGD peptide [CAS 1392278-76-0]
Partner: MedChemexpress LLC
| CAS No: | 1392278-76-0 |
| Applications: | Cancer-programmed cell death |
| MW: | 948.04 |
| Formula: | C35H57N13O14S2 |
| SMILES: | O=C([C@@H](N)CSSC[C@H](NC1=O)C(O)=O)N[C@H](C(NCC(N[C@H](C(N[C@H](C(NCC(N2[C@H](C(N[C@H]1CC(O)=O)=O)CCC2)=O)=O)CCCCN)=O)CC(O)=O)=O)=O)CCCNC(N)=N |
| Purity: | 99.57 |
| Description: | iRGD peptide is a 9-amino acid cyclic peptide, triggers tissue penetration of agents by first binding to av integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
